Medtronic Return on Investment 2010-2025 | MDT
Current and historical return on investment (ROI) values for Medtronic (MDT) over the last 10 years.
| Medtronic ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-04-30 | $5.95B | $73.90B | 8.07% |
| 2025-01-31 | $5.57B | $73.60B | 7.54% |
| 2024-10-31 | $5.41B | $73.32B | 7.25% |
| 2024-07-31 | $5.16B | $74.47B | 6.87% |
| 2024-04-30 | $5.15B | $74.35B | 6.82% |
| 2024-01-31 | $5.66B | $76.15B | 7.46% |
| 2023-10-31 | $5.57B | $75.39B | 7.40% |
| 2023-07-31 | $5.63B | $75.83B | 7.54% |
| 2023-04-30 | $5.49B | $76.01B | 7.49% |
| 2023-01-31 | $5.59B | $73.83B | 7.71% |
| 2022-10-31 | $5.86B | $72.81B | 7.99% |
| 2022-07-31 | $6.02B | $70.32B | 8.07% |
| 2022-04-30 | $5.75B | $73.09B | 7.53% |
| 2022-01-31 | $5.69B | $77.00B | 7.33% |
| 2021-10-31 | $5.30B | $77.77B | 6.83% |
| 2021-07-31 | $4.67B | $77.62B | 6.04% |
| 2021-04-30 | $4.48B | $77.98B | 5.88% |
| 2021-01-31 | $3.20B | $77.43B | 4.26% |
| 2020-10-31 | $3.56B | $76.28B | 4.76% |
| 2020-07-31 | $3.98B | $73.31B | 5.33% |
| 2020-04-30 | $4.79B | $72.89B | 6.38% |
| 2020-01-31 | $6.42B | $76.69B | 8.50% |
| 2019-10-31 | $6.32B | $75.47B | 8.46% |
| 2019-07-31 | $6.52B | $75.30B | 8.78% |
| 2019-04-30 | $6.27B | $74.70B | 8.48% |
| 2019-01-31 | $6.25B | $73.62B | 8.46% |
| 2018-10-31 | $6.14B | $73.39B | 8.24% |
| 2018-07-31 | $6.49B | $74.01B | 8.59% |
| 2018-04-30 | $6.64B | $74.52B | 8.71% |
| 2018-01-31 | $6.40B | $76.26B | 8.34% |
| 2017-10-31 | $6.11B | $77.52B | 7.98% |
| 2017-07-31 | $5.60B | $76.74B | 7.28% |
| 2017-04-30 | $5.38B | $76.25B | 6.90% |
| 2017-01-31 | $5.27B | $75.42B | 6.64% |
| 2016-10-31 | $5.48B | $79.30B | 6.71% |
| 2016-07-31 | $5.40B | $81.02B | 6.47% |
| 2016-04-30 | $5.36B | $82.17B | 6.32% |
| 2016-01-31 | $3.95B | $84.50B | 4.59% |
| 2015-10-31 | $3.87B | $85.96B | 5.05% |
| 2015-07-31 | $3.76B | $86.52B | 6.03% |
| 2015-04-30 | $3.77B | $86.98B | 7.82% |
| 2015-01-31 | $3.91B | $46.81B | 11.57% |
| 2014-10-31 | $3.66B | $29.15B | 12.47% |
| 2014-07-31 | $3.68B | $29.57B | 12.60% |
| 2014-04-30 | $3.81B | $29.76B | 13.23% |
| 2014-01-31 | $4.70B | $28.96B | 16.50% |
| 2013-10-31 | $4.89B | $28.38B | 17.77% |
| 2013-07-31 | $4.87B | $28.16B | 18.34% |
| 2013-04-30 | $4.76B | $28.41B | 18.51% |
| 2013-01-31 | $4.78B | $25.15B | 19.35% |
| 2012-10-31 | $4.71B | $24.53B | 19.03% |
| 2012-07-31 | $4.75B | $24.64B | 19.09% |
| 2012-04-30 | $4.75B | $24.47B | 19.11% |
| 2012-01-31 | $4.52B | $25.42B | 18.24% |
| 2011-10-31 | $4.51B | $24.96B | 18.78% |
| 2011-07-31 | $4.38B | $24.54B | 18.82% |
| 2011-04-30 | $4.30B | $24.08B | 19.06% |
| 2011-01-31 | $4.37B | $22.44B | 19.94% |
| 2010-10-31 | $4.49B | $21.97B | 21.00% |
| 2010-07-31 | $4.63B | $21.68B | 22.15% |
| 2010-04-30 | $4.71B | $21.57B | 23.19% |
| 2010-01-31 | $4.32B | $20.32B | 21.81% |
| 2009-10-31 | $4.03B | $19.98B | 20.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.928B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
| Boston Scientific (BSX) | United States | $147.560B | 37.59 |
| Stryker (SYK) | United States | $144.011B | 30.10 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
| ResMed (RMD) | United States | $36.560B | 27.72 |
| Agilent Technologies (A) | United States | $33.258B | 22.04 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
| Terumo (TRUMY) | Japan | $26.680B | 34.37 |
| Insulet (PODD) | United States | $21.438B | 84.69 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.71 |
| Baxter (BAX) | United States | $15.713B | 11.81 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.94 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.31 |
| ICU Medical (ICUI) | United States | $3.250B | 24.18 |
| Envista Holdings (NVST) | United States | $3.127B | 26.73 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.55 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 5.08 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.63 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 6.12 |
| Brainsway (BWAY) | Israel | $0.206B | 55.30 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.37 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 48.64 |
| United-Guardian (UG) | United States | $0.037B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |